التفاصيل البيبلوغرافية
| العنوان: |
Phase 1/2 trial of oral EPI-7386 (masofaniten) in combination with enzalutamide (Enz) compared to Enz alone in patients with metastatic castration-resistant prostate cancer (mCRPC): Phase 1 (P1) results and phase 2 (P2) design. |
| المؤلفون: |
Kyriakopoulos, Christos, Chatta, Gurkamal S., Laccetti, Andrew Leonard, Iannotti, Nicholas, Sokolova, Alexandra, Hotte, Sebastien J., Tutrone, Ronald F., Markowski, Mark Christopher, Nordquist, Luke T., Pili, Roberto, Saad, Fred, Zhang, Jingsong, Villaluna, Karen, Younginger, Brett, Le Moigne, Ronan, Cesano, Alessandra |
| المصدر: |
Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p141-141, 235p |
| قاعدة البيانات: |
Supplemental Index |
